Highlighting the Importance of Psoriatic Disease Awareness
On April 4, 2025, the International Federation of Psoriasis Associations (IFPA) will host the IFPA Forum 2025 in Bogotá. This significant event aims to unite stakeholders from various backgrounds to confront the pressing issues faced by individuals living with psoriatic disease. This Forum represents the third regional gathering of this kind, following the successful events in Europe and Asia.
Understanding Psoriatic Disease
Psoriatic disease is a long-standing, immune-mediated inflammatory condition that brings substantial physical, emotional, and financial challenges to millions around the globe. Current estimates show its prevalence in the Americas ranges from 0.1% to 1.7%, with rising rates notably in North America. However, there remains a lack of comprehensive data from regions like Central America and the Caribbean.
There is a critical need to address the disparities in access to effective treatments across the Americas. Individuals from ethnic minority communities in North America face challenges that hinder their healthcare access, while those in Latin America encounter broader social and systemic inequities. These stark disparities highlight the necessity for targeted, region-specific solutions that advocate for healthcare equity and prompt diagnosis and treatment for individuals living with chronic conditions like psoriatic disease.
Enhancing Treatment Accessibility
To optimize treatment solutions, it is essential to evaluate regional variations in disease burden, impact on quality of life, and accompanying health conditions. Establishing access to timely diagnoses and effective management strategies can significantly enhance health outcomes, improving the lives of those affected by this condition.
Advocacy at the Heart of Progress
For over twenty years, IFPA has championed the cause of psoriatic disease as a critical non-communicable disease. This commitment is evident in their efforts that led to the 2014 World Health Assembly Resolution and the 2016 WHO Global Report on Psoriasis. With members throughout the Americas, IFPA has taken a leading role in global advocacy initiatives aimed at raising awareness and addressing the health needs of those living with psoriatic disease.
Be a Part of the Change
For those wanting to learn more about the IFPA Forum 2025 and its objectives, further information is available on the IFPA's official channels.
About IFPA
The International Federation of Psoriasis Associations, established in 1971, stands as a unifying voice for the psoriatic disease community. Representing over 60 million individuals living with this condition, IFPA remains steadfast in its mission to advocate for progress and improved standards of living for those affected.
Frequently Asked Questions
What is the focus of the IFPA Forum 2025?
The IFPA Forum 2025 aims to address the inequities in access to care and improve the quality of life for individuals living with psoriatic disease across the Americas.
Where will the IFPA Forum 2025 take place?
The forum will be held in Bogotá, Colombia, on April 4, 2025.
Who is invited to participate in the forum?
Stakeholders from various sectors involved with psoriatic disease, including healthcare, advocacy groups, and patients, are encouraged to participate.
How does IFPA advocate for individuals living with psoriatic disease?
IFPA advocates through national and global efforts aimed at improving treatment access, awareness, and research related to psoriatic disease.
What has IFPA accomplished in its history?
IFPA has evidenced significant achievements, including the recognition of psoriatic disease as a major health concern through international resolutions and reports.
